Market Capitalization (Millions $) |
300 |
Shares
Outstanding (Millions) |
27 |
Employees |
- |
Revenues (TTM) (Millions $) |
20 |
Net Income (TTM) (Millions $) |
-235 |
Cash Flow (TTM) (Millions $) |
-115 |
Capital Exp. (TTM) (Millions $) |
0 |
Oyster Point Pharma Inc
Oyster Point Pharma Inc is a pharmaceutical company that focuses on developing and commercializing therapies for diseases affecting the ocular surface. The company specializes in treatments for dry eye disease, a common condition that affects millions of people around the world. Oyster Point Pharma is known for its innovative approach, utilizing neurostimulation technologies to address the underlying causes of dry eye disease. Their goal is to improve the quality of life for patients suffering from this condition by offering effective and innovative treatment options.
Company Address: 202 Carnegie Center, Suite 106 Princeton 8540 NJ
Company Phone Number: 382-9032 Stock Exchange / Ticker: NASDAQ OYST
|